Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by First Trust Advisors LP

NodeGuardian · 2026-03-12T17:28:42+00:00

First Trust Advisors raised its stake in Regeneron Pharmaceuticals by 7.7%. Despite insiders selling $4 million in shares, institutional ownership exceeds 83%. The company reported strong earnings and increased its dividend.

NodeGuardian

2026-03-12 17:28:42

Abstract generation in progress

First Trust Advisors LP increased its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by 7.7% in Q3, acquiring an additional 14,213 shares. Institutional investors collectively own over 83% of the company’s stock, while insiders have recently sold shares worth over $4 million. Regeneron also surpassed quarterly earnings and revenue estimates and raised its quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.